NATICK, Mass. -- Boston Scientific Corporation has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla™ Guide Extension Catheter and has launched the ...

NATICK, Mass., July 12, 2013 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla' Guide ...

- Device Facilitates Delivery of Interventional Devices in Complex PCI Procedures NATICK, Massachusetts, July 12, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food ...

The verdict was related to the patent infringement lawsuit initiated by Vascular Solutions, Inc. (VASC) on May 16, 2013, which claimed that Boston Scientific’s Guidezilla guide extension catheter ...

医薬品医療機器総合機構（PMDA）は10月28日、ボストン・サイエンティフィックジャパンの「冠血管向けバルーン拡張式血管形成術用カテーテル」（商品名：イマージPTCAバルーンカテーテルなど）と「冠動脈貫通用カテーテル」（商品名：Guidezilla ...

Boston Scientific Corporation ( BSX) is once again a hot topic of discussion among all financial market participants. Per the latest development, the company's Guidezilla guide extension catheter was ...

MINNEAPOLIS, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced today that the U.S. District Court for the District of Minnesota has granted Vascular Solutions' request ...

Boston Scientific is launching its Guidezilla catheter as Vascular Solutions pursues a patent infringement lawsuit.--Courtesy of Boston Scientific Boston Scientific ...

FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons DUBLIN - May 16, 2019 - Medtronic plc (MDT), a global leader ...

FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons DUBLIN - May 16, 2019 - Medtronic plc (NYSE:MDT), a global ...

Vascular Solutions claims Boston Scientific violated its GuideLiner patents.--Courtesy of Vascular Solutions Vascular Solutions is suing Boston Scientific ($BSX ...